|
| Products & Services > IPO > Synopsis Details |
|
Molbio Diagnostics Ltd
|
|
investors@molbiodiagnostics.com Website:www.molbiodiagnostics.com
|
|
Initial public offering of up to 11,644,314 equity shares of face value of Re. 1 each of the company ("Equity Shares") for cash at a price of Rs. 807 per equity share (including a share premium of Rs. 806 per equity share) ("Offer Price") aggregating up to Rs. 939.70 Crores ("Offer"). The offer comprises a fresh issue of up to 2,478,314 equity shares of face value of Re. 1 each aggregating up to Rs. 200.00 Crores ("Fresh Issue") and an offer for sale of up to 9,166,000 equity shares of face value of Re. 1 each ("Offered Shares") aggregating up to Rs. 739.70 Crores, comprising up to 1,811,000 equity shares of face value of Re. 1 each aggregating up to Rs. 146.15 Crores by Exxora Trading LLP, up to 1,221,000 equity shares of face value of Re. 1 each aggregating up to Rs. 98.53 Crores by Chandrasekhar Bhaskaran Nair (Jointly Held with Anita Angela Chandrasekhar), up to 48,000 equity shares of face value of Re. 1 each aggregating up to Rs. 3.87 Crores by Abdul Qadir Mohamed Theruvath, up to 193,000 equity shares of face value of Re. 1 each aggregating up to Rs. 15.58 Crores by Chewbacca Services Limited, up to 902,000 equity shares of face value of Re. 1 each aggregating up to Rs. 72.79 Crores by J. Guru Dutt (Jointly Held with Sandhya Guru Dutt), up to 1,125,000 equity shares of face value of Re. 1 each aggregating up to Rs. 90.79 Crores by Gopalkrishna Mangalore Kini, up to 902,000 equity shares of face value of Re. 1 each aggregating up to Rs. 72.79 Crores by Gopalakrishna Sampathgiri (Jointly Held with Jayshree Sampathgiri), up to 1,000,000 equity shares of face value of Re. 1 each aggregating up to Rs. 80.7 Crores by India Business Excellence Fund III, up to 17,000 equity shares of face value of Re. 1 each aggregating up to Rs. 1.37 Crores by M Ganesh Kamath, up to 248,000 equity shares of face value of Re. 1 each aggregating up to Rs. 20.01 Crores by M.A. Rohit, up to 202,000 equity shares of face value of Re. 1 each aggregating up to Rs. 16.30 Crores by M.A. Sharath, up to 451,000 equity shares of face value of Re. 1 each aggregating up to Rs. 36.40 Crores by M.A. Usha Rani, up to 452,000 equity shares of face value of Re. 1 each aggregating up to Rs. 36.48 Crores by Sangeetha M Kini, up to 97,000 equity shares of face value of Re. 1/- each aggregating up to Rs. 7.83 Crores by Shaheeda Abdul Kader, up to 226,000 equity shares of face value of Re. 1 each aggregating up to Rs. 18.24 Crores by Shruti G Kini, up to 193,000 equity shares of face value of Re. 1 each aggregating up to Rs. 15.58 Crores by Sujay Limited, up to 78,000 equity shares of face value of Re. 1 each aggregating up to Rs. 6.29 Crores by V Sciences Investments Pte. Ltd., and up to 78,000 equity shares of face value of Re. 1/- each aggregating up to Rs. [*] crores by Vivek Devaraj (together, the "Selling Shareholders", and such offer for sale of equity shares by the selling shareholders, the "Offer for Sale").
This offer includes a reservation of up to 18,587 equity shares of face value of Re. 1/- each aggregating up to Rs. 1.5 (constituting up to [*]% of the post-offer paid-up equity share capital) for subscription by eligible employees (the "Employee Reservation Portion"). The company in consultation with the brlms, may offer a discount of Rs 76 per equity share of face value of Re. 1 each, to eligible employees bidding in the employee reservation portion ("Employee Discount"), subject to necessary approvals as may be required the offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The offer and the net offer would constitute [*]% and [*]%, respectively, of the company post-offer paid-up equity share capital.
Price Band: Rs. 768 to Rs. 807 per equity share of face value of Rs. 1 each.
The floor price and the cap price are 768 times and 807 times the face value of the equity shares, respectively.
Bids can be made for a minimum of 18 equity shares of face value of Rs. 1 each and in multiples of 18 equity shares of face value of Rs. 1 each thereafter.
A discount of Rs. 76.00 per equity share is being offered to eligible employees bidding in the employee reservation portion.
The price band and the minimum bid lot will be decided
by the company.
|
|
|
|
|
|
|
Molbio Diagnostics Ltd
|
| |
Rs Cr |
Lead Managers to the Issue |
| 0.00 |
| IIFL Capital Services Limited |
| Jefferies India Private Limited |
| Kotak Mahindra Capital Company Limited |
| Motilal Oswal Investment Advisors Limited |
|
| 903.95 |
|
| 12.44 |
|
| Rs.
768.00
|
|
|
|
|
|
| Projects |
|
Funding capital expenditure towards the setting up of infrastructure for the company research and development facility, Center of Excellence and connected office space
|
Funding capital expenditure towards the purchase of certain plant, machinery and other equipment for unit 1 & 2
|
|
General corporate purposes
| |
|
|
| Chandrasekhar Bhaskaran Nair |
|
|
|
| |
|
|
|
|
 |
|